BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 26.3] [Reference Citation Analysis]
Number Citing Articles
1 Schultheiß M, Bettinger D, Thimme R, Rössle M. 30 Jahre transjugulärer intrahepatischer portosystemischer Shunt (TIPS) – Rückblick und Perspektive. Z Gastroenterol 2020;58:877-89. [DOI: 10.1055/a-1217-7866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lisman T, Intagliata NM. Bleeding and Thrombosis in Patients with Liver Diseases. Semin Thromb Hemost 2020;46:653-5. [PMID: 32932541 DOI: 10.1055/s-0040-1715453] [Reference Citation Analysis]
3 Violi F, Loffredo L, Pastori D. Anticoagulation in patients with advanced liver disease: an open issue. Intern Emerg Med 2021;16:61-71. [PMID: 33073317 DOI: 10.1007/s11739-020-02526-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Dong G, Huang XQ, Zhu YL, Ding H, Li F, Chen SY. Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis. Ann Transl Med 2021;9:289. [PMID: 33708916 DOI: 10.21037/atm-20-4912] [Reference Citation Analysis]
5 Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Schiano T, Mascarenhas J. Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation. J Thromb Thrombolysis 2020;50:652-60. [PMID: 32034618 DOI: 10.1007/s11239-020-02052-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
6 Mandorfer M, Turon F, Lens S, Baiges A, García-Criado Á, Darnell A, Belmonte E, Ferrusquía-Acosta J, Magaz M, Perez-Campuzano V, Olivas P, Bauer D, Casanovas G, Torres F, Mariño Z, Forns X, Hernández-Gea V, García-Pagán JC. Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response. Liver Int 2021. [PMID: 34242479 DOI: 10.1111/liv.15009] [Reference Citation Analysis]
7 Stotts MJ, Lisman T, Intagliata NM. The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis. Semin Thromb Hemost 2020;46:716-23. [PMID: 32820482 DOI: 10.1055/s-0040-1715449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu Y, Li H, Zhang T, Bai Z, Xu X, Levi Sandri GB, Wang L, Qi X. Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis. Adv Ther 2021;38:1904-30. [PMID: 33687650 DOI: 10.1007/s12325-021-01652-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Zheng SM, Lin N, Tang SH, Yang JY, Wang HQ, Luo SL, Zhang Y, Mu D. Isolated hepatic tuberculosis associated with portal vein thrombosis and hepatitis B virus coinfection: A case report and review of the literature. World J Clin Cases 2021; 9(30): 9310-9319 [PMID: 34786418 DOI: 10.12998/wjcc.v9.i30.9310] [Reference Citation Analysis]
10 Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Tsuzuki T, Ishigami M. Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis. Hepatol Res 2021. [PMID: 34687492 DOI: 10.1111/hepr.13725] [Reference Citation Analysis]
11 Naymagon L, Tremblay D, Mascarenhas J, Schiano T. Characteristics, anticoagulation, and outcomes of portal vein thrombosis after intra-abdominal surgery. Surgery 2021;169:1175-81. [PMID: 33358635 DOI: 10.1016/j.surg.2020.11.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ni K, Jansson-Knodell C, Krosin ME, Obaitan I, Haste PM, Nephew LD, Sagi SV. Ruptured idiopathic hepatic artery pseudoaneurysm causing portal vein thrombosis with portal hypertension and variceal bleeding. Radiol Case Rep 2021;16:824-8. [PMID: 33552333 DOI: 10.1016/j.radcr.2021.01.032] [Reference Citation Analysis]
13 Fortea JI, Carrera IG, Puente Á, Cuadrado A, Huelin P, Tato CÁ, Fernández PÁ, Montes MDRP, Céspedes JN, López AB, Sanchez FJG, Hoyos ML, Crespo J, Fábrega E. Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders. J Clin Med 2020;9:E2822. [PMID: 32878264 DOI: 10.3390/jcm9092822] [Reference Citation Analysis]
14 Yang C, Liu J, Shi Q, Huang S, Zhou C, Wang Y, Li T, Chen Y, Xiong B. Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2021. [PMID: 33973270 DOI: 10.1111/jgh.15543] [Reference Citation Analysis]
15 Ronca V, Podda GM, Cattaneo M. An "unmodifiable" risk factor that has been modified. Intern Emerg Med 2021;16:157-9. [PMID: 31396923 DOI: 10.1007/s11739-019-02170-9] [Reference Citation Analysis]
16 Kühn F, Schiergens TS, Klar E. Acute Mesenteric Ischemia. Visc Med 2020;36:256-62. [PMID: 33005650 DOI: 10.1159/000508739] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
17 Biolato M, Paratore M, Di Gialleonardo L, Marrone G, Grieco A. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence? World J Hepatol 2022; 14(4): 682-695 [DOI: 10.4254/wjh.v14.i4.682] [Reference Citation Analysis]
18 Zhan C, Prabhu V, Kang SK, Li C, Zhu Y, Kim S, Olsen S, Jacobson IM, Dagher NN, Carney B, Hickey RM, Taslakian B. Comparison of Non-Tumoral Portal Vein Thrombosis Management in Cirrhotic Patients: TIPS Versus Anticoagulation Versus No Treatment. J Clin Med 2021;10:2316. [PMID: 34073236 DOI: 10.3390/jcm10112316] [Reference Citation Analysis]
19 Galante A, De Gottardi A. Portal vein thrombosis: an overview of current treatment options. Acta Gastroenterol Belg 2021;84:327-32. [PMID: 34217184 DOI: 10.51821/84.2.327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Quan X, Tai Y, Wei B, Tong H, Wang Z, Yang Y, Wu H. Angioplasty With Stent Implantation for Portal Venous Stenosis Caused by Abdominal Tuberculosis: A Case Report and Literature Review. Front Med (Lausanne) 2021;8:778672. [PMID: 34778328 DOI: 10.3389/fmed.2021.778672] [Reference Citation Analysis]
21 Levigard RB, Salas H, Serrão H, Diniz F, Nogueira CAV, de Oliveira AA, Leite NC, Ladeira M, Chindamo MC, Pereira G. Liver Growth and Portal Hypertension Improvement After Percutaneous Recanalization of Chronic Portal Vein Thrombosis in Non-Cirrhotic Participants. Cardiovasc Intervent Radiol 2022. [PMID: 35166884 DOI: 10.1007/s00270-022-03065-7] [Reference Citation Analysis]
22 Praktiknjo M, Simón-talero M, Römer J, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Maurer MH, Zipprich A, Triolo M, Maleux G, Fialla AD, Dam C, Vidal-gonzález J, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, López M, Jansen C, Chang J, Schierwagen R, Uschner F, Kukuk G, Meyer C, Thomas D, Wolter K, Strassburg CP, Laleman W, La Mura V, Ripoll C, Berzigotti A, Calleja JL, Tandon P, Hernandez-gea V, Reiberger T, Albillos A, Tsochatzis EA, Krag A, Genescà J, Trebicka J, Quiroga S, Yu D, Téllez L, Mandorfer M, Garcia-pagan JC, Berbel C, Ferrusquia J, Ble M, Garcia-criado MA, Belmonte E, Ney M, Margini C, Casu S, Murgia G, Ludwig C, Stangl F. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. Journal of Hepatology 2020;72:1140-50. [DOI: 10.1016/j.jhep.2019.12.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 16.0] [Reference Citation Analysis]
23 Gao Z, Zhao J, Liu X, Li S, Wang M, Gao Y. Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: a retrospective, multicentre, nested case-control study. Hepatol Int 2021. [PMID: 34292507 DOI: 10.1007/s12072-021-10224-4] [Reference Citation Analysis]
24 Kimura N, Tsuchiya A, Oda C, Kimura A, Hosaka K, Tominaga K, Hayashi K, Abé T, Umezu H, Terai S. Portal Vein Thrombosis Associated with Trousseau Syndrome due to Urinary Bladder Squamous Cell Carcinoma in a Liver Cirrhosis Patient. Intern Med 2020;59:1971-5. [PMID: 32448831 DOI: 10.2169/internalmedicine.4112-19] [Reference Citation Analysis]
25 Valeriani E, Di Nisio M, Riva N, Cohen O, Porreca E, Senzolo M, De Gottardi A, Magaz M, Garcia-Pagan JC, Ageno W. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Thromb Haemost 2021;121:867-76. [PMID: 33525037 DOI: 10.1055/s-0040-1722192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Yuan HL, Wang M, Chu WW, Li FX, Lu JJ, Li Y. Nomogram Model for Prediction of Portal Vein Thrombosis in Patients with Liver Cirrhosis After Splenectomy: A Retrospective Analysis of 2 Independent Cohorts. Med Sci Monit 2021;27:e929844. [PMID: 34075015 DOI: 10.12659/MSM.929844] [Reference Citation Analysis]
28 Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis 2021;22:176-86. [PMID: 33470535 DOI: 10.1111/1751-2980.12970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Shukla A, Giri S. Portal Vein Thrombosis in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.11.003] [Reference Citation Analysis]
30 Zhou T, Sun X, Zhou T, Li Y, Chen X, Cheng B, Gao Y. Efficacy and Safety of Nadroparin Calcium-Warfarin Sequential Anticoagulation in Portal Vein Thrombosis in Cirrhotic Patients: A Randomized Controlled Trial. Clin Transl Gastroenterol 2020;11:e00228. [PMID: 32858573 DOI: 10.14309/ctg.0000000000000228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
31 Jahantab MB, Mehrabi S, Salehi V, Abedini L, Yavari Barhaghtalab MJ. Portal Vein Thrombosis following Total Colectomy due to Colonic Inertia: A Case Report and Evaluation of Risk Factors. Case Rep Hematol 2021;2021:8895206. [PMID: 33532102 DOI: 10.1155/2021/8895206] [Reference Citation Analysis]
32 Okumura K, Schluger A, Dhand A, Bodin R, Nishida S. Hepatopulmonary Syndrome: Unique Radiological Association with Portal Vein Thrombosis and Porto-systemic Shunting. Journal of Liver Transplantation 2022. [DOI: 10.1016/j.liver.2022.100101] [Reference Citation Analysis]
33 Wu WY, Kong DR. Advances in diagnosis and treatment of portal venous thrombosis. Shijie Huaren Xiaohua Zazhi 2021; 29(4): 165-173 [DOI: 10.11569/wcjd.v29.i4.165] [Reference Citation Analysis]
34 Xing Y, Tian Z, Jiang Y, Guan G, Niu Q, Sun X, Han R, Jing X. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis. Annals of Medicine 2022;54:302-9. [DOI: 10.1080/07853890.2022.2028893] [Reference Citation Analysis]
35 Shen Y, Ma W, Hang Y, Liu LL, Jiang W, Wu SD. Clinical application of liver stiffness measurement in patients with cavernous transformation of portal vein. Exp Ther Med 2021;21:442. [PMID: 33777190 DOI: 10.3892/etm.2021.9881] [Reference Citation Analysis]
36 Kushiro S, Miyagami T, Kanai Y, Yang KS, Naito T. Delayed Diagnosis of Portal Vein Thrombosis Due to Premature Closure of Cholecystitis. Am J Med 2021;134:e543-5. [PMID: 34197785 DOI: 10.1016/j.amjmed.2021.05.015] [Reference Citation Analysis]
37 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 28.0] [Reference Citation Analysis]
38 Scheiner B, Northup PG, Lisman T, Mandorfer M. Author response to Letter to the Editor: 'AB0, von Willebrand factor/Factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit?'. Liver Int 2020;40:1790-1. [PMID: 32367685 DOI: 10.1111/liv.14499] [Reference Citation Analysis]
39 Nicoară-Farcău O, Soy G, Magaz M, Baiges A, Turon F, Garcia-Criado A, Barrufet M, Burrel M, Hernández-Gea V, García-Pagán JC. New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis. Semin Thromb Hemost 2020;46:673-81. [PMID: 32820481 DOI: 10.1055/s-0040-1715473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Bailey KE, Tranovich MJ. Portal Venous Thrombosis Associated with Use of Etonogestrel/ethinyl Estradiol Vaginal Ring. Clin Pract Cases Emerg Med 2020;4:263-6. [PMID: 32426689 DOI: 10.5811/cpcem.2020.1.44654] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Khemichian S, Terrault NA. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease. Semin Thromb Hemost. 2020;46:682-692. [PMID: 32820479 DOI: 10.1055/s-0040-1715451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
42 Fan X, Huang X, Hershman M, Zheng X, Jiang C, Yue B, Weisberg I. Portal vein thrombosis prevalence and mortality among alcoholic cirrhosis in a nationwide inpatient cohort. Eur J Gastroenterol Hepatol 2020;32:1160-7. [PMID: 31834054 DOI: 10.1097/MEG.0000000000001624] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Lebreton A, Sinegre T, Lecompte T, Talon L, Abergel A, Lisman T. Thrombin Generation and Cirrhosis: State of the Art and Perspectives. Semin Thromb Hemost 2020;46:693-703. [PMID: 32820480 DOI: 10.1055/s-0040-1715102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
44 De Maria C, Galante A, Fasoli A, De Gottardi A. When and how to use direct oral anticoagulants in patients with advanced chronic liver disease? Curr Opin Pharmacol 2021;60:111-6. [PMID: 34403992 DOI: 10.1016/j.coph.2021.07.006] [Reference Citation Analysis]
45 Pan Y, Mei J, Chen J, Zhang D, Wang J, Wang X, Yi M, Zhou Z, Zhang Y, Chen M, Guo R, Xu L. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma. Ann Surg Oncol 2021. [PMID: 34637058 DOI: 10.1245/s10434-021-10903-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Naymagon S, Mascarenhas J, Schiano T. The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:215-23. [PMID: 32185400 DOI: 10.1093/ibd/izaa053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Qi Y, Hu X, Chen J, Ying X, Shi Y. The Risk Factors of VTE and Survival Prognosis of Patients With Malignant Cancer: Implication for Nursing and Treatment. Clin Appl Thromb Hemost 2020;26:1076029620971053. [PMID: 33119403 DOI: 10.1177/1076029620971053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Intagliata NM, Davitkov P, Allen AM, Falck-Ytter YT, Stine JG. AGA Technical Review on Coagulation in Cirrhosis. Gastroenterology 2021;161:1630-56. [PMID: 34579937 DOI: 10.1053/j.gastro.2021.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Zhang JB, Chen J, Zhou J, Wang XM, Chen S, Chu JG, Liu P, Ye ZD. Systematic review and meta-analysis of trans-jugular intrahepatic portosystemic shunt for cirrhotic patients with portal vein thrombosis. World J Clin Cases 2021; 9(19): 5179-5190 [PMID: 34307565 DOI: 10.12998/wjcc.v9.i19.5179] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Fiel MI, Schiano TD. Idiopathic noncirrhotic portal hypertension. Seminars in Diagnostic Pathology 2019;36:395-403. [DOI: 10.1053/j.semdp.2019.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
51 Benmassaoud A, Rodger M. Challenging anticoagulation cases: Acute extensive portal vein thrombosis in a patient without cirrhosis - Evidence-based management of a rare clinical entity. Thromb Res 2021;206:133-6. [PMID: 34464871 DOI: 10.1016/j.thromres.2021.08.013] [Reference Citation Analysis]
52 Caldwell S, Carlini LE. Coagulation Homeostasis in Liver Disease. Clin Liver Dis (Hoboken) 2020;16:137-41. [PMID: 33163164 DOI: 10.1002/cld.935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Koh JH, Liew ZH, Ng GK, Liu HT, Tam YC, De Gottardi A, Wong YJ. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis. Dig Liver Dis 2021:S1590-8658(21)00408-4. [PMID: 34393072 DOI: 10.1016/j.dld.2021.07.039] [Reference Citation Analysis]
54 Sofia C, Cattafi A, Silipigni S, Pitrone P, Carerj ML, Marino MA, Pitrone A, Ascenti G. Portal vein thrombosis in patients with chronic liver diseases: From conventional to quantitative imaging. Eur J Radiol 2021;142:109859. [PMID: 34284232 DOI: 10.1016/j.ejrad.2021.109859] [Reference Citation Analysis]
55 Zhao J, Li JR, Zhang AJ, Li XL, Liang J, Zheng AP. Relationship between portal vein width and portal vein thrombosis in patients with hepatitis B cirrhosis. Shijie Huaren Xiaohua Zazhi 2022; 30(1): 24-29 [DOI: 10.11569/wcjd.v30.i1.24] [Reference Citation Analysis]
56 García-Pagán JC, Saffo S, Mandorfer M, Garcia-Tsao G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep 2020;2:100122. [PMID: 32671331 DOI: 10.1016/j.jhepr.2020.100122] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
57 Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Troy K, Schiano T, Mascarenhas J. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. Blood Adv 2020;4:655-66. [PMID: 32078681 DOI: 10.1182/bloodadvances.2019001310] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
58 Fujiwara Y, Yamaguchi T, Nakane M. Portal Vein Thrombosis in Metastatic Colorectal Cancer During FOLFIRI-bevacizumab Chemotherapy Successfully Treated with Apixaban. Intern Med 2021;60:53-7. [PMID: 32788527 DOI: 10.2169/internalmedicine.5456-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Tiede A, Zieger B, Lisman T. Acquired bleeding disorders. Haemophilia 2022;28 Suppl 4:68-76. [PMID: 35521729 DOI: 10.1111/hae.14548] [Reference Citation Analysis]
60 Sieloff EM, Garg A, Goyal S, Alangaden A, Lilley KK. A Rare Presentation of Non-Hodgkin's Lymphoma Presenting With Bleeding Esophageal Varices Secondary to a Malignant Portal Vein Tumor Thrombosis. Cureus 2020;12:e9162. [PMID: 32676259 DOI: 10.7759/cureus.9162] [Reference Citation Analysis]
61 Mathew C, Zumberg M. Clots in unusual places: lots of stress, limited data, critical decisions. Hematology Am Soc Hematol Educ Program 2021;2021:92-9. [PMID: 34889361 DOI: 10.1182/hematology.2021000237] [Reference Citation Analysis]
62 Li H, Sun PM, Sun HW, Cui Y. Progress in clinical diagnosis and treatment of cavernous transformation of the portal vein. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 662-669 [DOI: 10.11569/wcjd.v29.i12.662] [Reference Citation Analysis]
63 Li B, He Q, Lu G, Hong C, Chen J. Minor role of hemostatic alternation in portal vein thrombosis pathogenesis revealed by global measurement. J Hepatol 2021:S0168-8278(21)02031-6. [PMID: 34509525 DOI: 10.1016/j.jhep.2021.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Allaire M, Walter A, Sutter O, Nahon P, Ganne-carrié N, Amathieu R, Nault J. TIPS for management of portal-hypertension-related complications in patients with cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2020;44:249-63. [DOI: 10.1016/j.clinre.2019.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Xu S, Guo X, Yang B, Romeiro FG, Primignani M, Méndez-Sánchez N, Yoshida EM, Mancuso A, Tacke F, Noronha Ferreira C, De Stefano V, Qi X. Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review. Clin Transl Gastroenterol 2021;12:e00409. [PMID: 34597281 DOI: 10.14309/ctg.0000000000000409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Lim J, Kim HI, Kim E, Kim J, An J, Chang S, Kim SO, Lee HC, Lee YS, Shim JH. Variceal bleeding is aggravated by portal venous invasion of hepatocellular carcinoma: a matched nested case-control study. BMC Cancer 2021;21:11. [PMID: 33402105 DOI: 10.1186/s12885-020-07708-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Sarquis LM, Trintinalha PDO, Michaelis W, Santos Filho AL, Yokoyama RA, Michaelis T, Smaniotto AP, Oliveira MS. Trombose de veia porta não associada à cirrose – desafio terapêutico. J vasc bras 2022;21:e20210013. [DOI: 10.1590/1677-5449.210013] [Reference Citation Analysis]
68 Lisman T, Caldwell SH, Intagliata NM. Haemostatic alterations and management of haemostasis in patients with cirrhosis. J Hepatol 2022;76:1291-305. [PMID: 35589251 DOI: 10.1016/j.jhep.2021.11.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Khan AR, Wei X, Xu X. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides. J Hepatocell Carcinoma 2021;8:1089-115. [PMID: 34522691 DOI: 10.2147/JHC.S318070] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Rugivarodom M, Charatcharoenwitthaya P. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis. J Clin Transl Hepatol 2020;8:432-44. [PMID: 33447527 DOI: 10.14218/JCTH.2020.00067] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Guarino M, Cucchetti A, Pontillo G, Farinati F, Benevento F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Rodolfo S, Cabibbo G, Marra F, Mega A, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Trevisani F, Giannini EG, Morisco F; ITA.LI.CA Group. Pattern of macrovascular invasion in hepatocellular carcinoma. Eur J Clin Invest 2021;51:e13542. [PMID: 33755196 DOI: 10.1111/eci.13542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Wang L, Guo X, Xu X, Xu S, Han J, Wang R, Guo Z, Yi F, Qi X. No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis. Clin Appl Thromb Hemost 2021;27:10760296211010969. [PMID: 33882699 DOI: 10.1177/10760296211010969] [Reference Citation Analysis]
73 Buso G, Becchetti C, Berzigotti A. Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review. Dig Liver Dis 2021;53:937-49. [PMID: 34120860 DOI: 10.1016/j.dld.2021.05.021] [Reference Citation Analysis]
74 Kotsifa E, Kykalos S, Machairas N, Nikiteas N, Sotiropoulos GC. Management of portal vein thrombosis in cirrhotic patients enlisted for liver transplantation: From diagnosis to treatment (Review). Biomed Rep 2021;15:94. [PMID: 34631049 DOI: 10.3892/br.2021.1470] [Reference Citation Analysis]
75 Zanetto A, Barbiero G, Battistel M, Sciarrone SS, Shalaby S, Pellone M, Battistella S, Gambato M, Germani G, Russo FP, Burra P, Senzolo M. Management of portal hypertension severe complications. Minerva Gastroenterol (Torino) 2021;67:26-37. [PMID: 33140623 DOI: 10.23736/S2724-5985.20.02784-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Chen H, Lei J, Liang S, Luo G, Deng M, Lü M. Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis. Can J Gastroenterol Hepatol 2021;2021:8859602. [PMID: 34007837 DOI: 10.1155/2021/8859602] [Reference Citation Analysis]
77 Hartl L, Jachs M, Simbrunner B, Bauer DJM, Semmler G, Gompelmann D, Szekeres T, Quehenberger P, Trauner M, Mandorfer M, Scheiner B, Reiberger T. Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19. J Pers Med 2021;11:1264. [PMID: 34945736 DOI: 10.3390/jpm11121264] [Reference Citation Analysis]
78 Minotti B, Bergamin I, Ow DV. [Abdominal Pain Caused by Viral Infection Is Not Always Trivial]. Praxis (Bern 1994) 2021;110:449-51. [PMID: 34107763 DOI: 10.1024/1661-8157/a003700] [Reference Citation Analysis]
79 Brichard M, Iesari S, Lerut J, Reding R, Goffette P, Coubeau L. Meso-Rex bypass for the management of extrahepatic portal vein obstruction in adults (with video). Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00159-4. [PMID: 34426078 DOI: 10.1016/j.hbpd.2021.08.003] [Reference Citation Analysis]
80 Manatsathit W, Patel K, Enke T, Sayles H, Jophlin LL, Merani S. Increased Morbidity and Mortality of Patients with Non-cirrhotic Portal Vein Thrombosis After Abdominal and Pelvic Surgeries: a Study of the National Inpatient Sample 2002 to 2015. J Gastrointest Surg 2021;25:2026-34. [PMID: 33037558 DOI: 10.1007/s11605-020-04818-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Teng F, Sun KY, Fu ZR. Tailored classification of portal vein thrombosis for liver transplantation: Focus on strategies for portal vein inflow reconstruction. World J Gastroenterol 2020; 26(21): 2691-2701 [PMID: 32550747 DOI: 10.3748/wjg.v26.i21.2691] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
82 Naymagon L. Venous thrombosis of the liver: current and emerging concepts in management. Transl Res 2020;225:54-69. [PMID: 32407789 DOI: 10.1016/j.trsl.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
83 Gairing SJ, Kloeckner R, Pitton MB, Baumgart J, von Auer-Wegener C, Lang H, Galle PR, Foerster F, Schattenberg JM. Multidisciplinary approach to the complex treatment for non-cirrhotic portal hypertension - case-report-based discussion. Z Gastroenterol 2021;59:43-9. [PMID: 33429449 DOI: 10.1055/a-1330-9827] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Zhang Y, Xu BY, Wang XB, Zheng X, Huang Y, Chen J, Meng ZJ, Gao YH, Qian ZP, Liu F, Lu XB, Shi Y, Shang J, Li H, Wang SY, Yin S, Sun SN, Hou YX, Xiong Y, Chen J, Li BL, Lei Q, Gao N, Ji LJ, Li J, Jie FR, Zhao RH, Liu JP, Lin TF, Chen LY, Tan WT, Zhang Q, Zou CC, Huang ZB, Jiang XH, Luo S, Liu CY, Zhang YY, Li T, Ren HT, Wang SJ, Deng GH, Xiong SE, Liu XX, Wang C, Yuan W, Gu WY, Qiao L, Wang TY, Wu DD, Dong FC, Li H, Hua J. Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation. Clin Gastroenterol Hepatol 2020;18:2564-2572.e1. [PMID: 32109631 DOI: 10.1016/j.cgh.2020.02.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
85 Park J, Chong T, Awwal TA, Aslam HM, Wallach SL. A Case of Idiopathic Portal Vein Thrombosis in an Immunocompetent Female. Cureus 2021;13:e18817. [PMID: 34804674 DOI: 10.7759/cureus.18817] [Reference Citation Analysis]
86 Lin H, Bai Z, Meng F, Wu Y, Luo L, Shukla A, Yoshida EM, Guo X, Qi X. Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:744505. [PMID: 35111772 DOI: 10.3389/fmed.2021.744505] [Reference Citation Analysis]
87 Wang L, Guo X, Shao X, Xu X, Zheng K, Wang R, Chawla S, Basaranoglu M, Qi X. Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case–control study. Therap Adv Gastroenterol 2022;15:175628482210875. [DOI: 10.1177/17562848221087536] [Reference Citation Analysis]
88 Tiede A, Zieger B, Lisman T. Acquired bleeding disorders. Haemophilia 2021;27 Suppl 3:5-13. [PMID: 32476241 DOI: 10.1111/hae.14033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
89 Scheiner B, Northup PG, Gruber AB, Semmler G, Leitner G, Quehenberger P, Thaler J, Ay C, Trauner M, Reiberger T, Lisman T, Mandorfer M. The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease. Liver Int 2020;40:1415-26. [PMID: 32052552 DOI: 10.1111/liv.14404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
90 Oliveira CAM, Trevizoli NC, Romeres SGB, Obeid EJ, Paludetto G, Ferreira GSA, De Campos PB, Ullmann RFB, Rocha HC, Figueira AVF, Diaz LGG, Jorge FMF, Caja GON, Watanabe ALC. Liver Transplantation After Acute Portal Vein Thrombosis: Case Report. Transplant Proc 2022:S0041-1345(22)00269-X. [PMID: 35597672 DOI: 10.1016/j.transproceed.2022.04.004] [Reference Citation Analysis]
91 van Dam LF, Klok FA, Tushuizen ME, Ageno W, Darwish Murad S, van Haren GR, Huisman MV, Lauw MN, Iglesias Del Sol A, Wasser MNJM, Willink Y, Kroft LJM. Magnetic Resonance Thrombus Imaging to Differentiate Acute from Chronic Portal Vein Thrombosis. TH Open 2020;4:e224-30. [PMID: 32984756 DOI: 10.1055/s-0040-1716716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Feldman ZM, Wang LJ, Chou EL, Latz CA, Sumpio BJ, Eagleton MJ, Conrad MF. Venous mesenteric ischemia carries high procedural burden and elevated mortality in patients with severe presentation. J Vasc Surg Venous Lymphat Disord. 2021;. [PMID: 33741519 DOI: 10.1016/j.jvsv.2021.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Jiang M, Mu J, Shen S, Zhang H. COVID-19 With Preexisting Hypercoagulability Digestive Disease. Front Med (Lausanne) 2020;7:587350. [PMID: 33521013 DOI: 10.3389/fmed.2020.587350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Dong S, Qi H, Li Y, Men P, Alifu M, Zhang Y, Li Y, Zhao R. A systematic review and meta-analysis of anticoagulation therapy for portal vein thrombosis in patients with cirrhosis: to treat or not to treat? Hepatol Int 2021. [PMID: 34487316 DOI: 10.1007/s12072-021-10233-3] [Reference Citation Analysis]
95 Chen Z, Ran T, Cao H, Xu F, Zhou ZH, He S. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study. Front Med (Lausanne) 2021;8:685944. [PMID: 34262917 DOI: 10.3389/fmed.2021.685944] [Reference Citation Analysis]
96 Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Adv Ther 2021;38:495-520. [PMID: 33155180 DOI: 10.1007/s12325-020-01550-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
97 Kmeid M, Liu X, Ballentine S, Lee H. Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data. Gastroenterology Res 2021;14:49-65. [PMID: 34007347 DOI: 10.14740/gr1376] [Reference Citation Analysis]
98 Ghazaleh S, Beran A, Aburayyan K, Nehme C, Patel D, Khader Y, Sharma S, Aziz M, Abdel-Aziz Y, Hammad T, Nawras A. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis: a systematic review and meta-analysis. Ann Gastroenterol 2021;34:104-10. [PMID: 33414629 DOI: 10.20524/aog.2020.0544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
99 Hayashi M, Sugaya T, Fujita M, Nakamura J, Imaizumi H, Abe K, Takahashi A, Takagi T, Hikichi T, Ohira H. Sigmoid Colon Varices due to Massive Thrombosis of a Noncirrhotic Extrahepatic Portosystemic Shunt. Intern Med 2020;59:2705-10. [PMID: 32669497 DOI: 10.2169/internalmedicine.4925-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]